Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

Nevin Murray, Robert B. Livingston, Frances A. Shepherd, Keith James, Benny Zee, A. Langleben, Michael Kraut, James Bearden, J. Wendall Goodwin, Clive Grafton, Andrew Turrisi, David Walde, Herbert Croft, David Osoba, Jon Ottaway, David Gandara

Research output: Contribution to journalArticlepeer-review

111 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences